- KASL clinical practice guidelines: management of hepatitis C
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363030
- Clin Mol Hepatol.
- 2016 Mar;22(1):76-139.
- doi: 10.3350/cmh.2016.22.1.76
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Resistance to Adefovir in Patients with Chronic Hepatitis B
-
Ryu SH, Chung YH
- KMID: 938252
- Korean J Hepatol.
- 2006 Dec;12(4):484-492.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Hepatitis B Virus Resistant to Lamivudine and Adefovir
-
Kim JW
- KMID: 1767700
- Korean J Gastroenterol.
- 2009 May;53(5):329-330.
- doi: 10.4166/kjg.2009.53.5.329
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines: management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2363029
- Clin Mol Hepatol.
- 2016 Mar;22(1):18-75.
- doi: 10.3350/cmh.2016.22.1.18
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C Virus and Antiviral Drug Resistance
-
Kim S, Han KH, Ahn SH
- KMID: 2412093
- Gut Liver.
- 2016 Nov;10(6):890-895.
- doi: 10.5009/gnl15573
Since its discovery in 1989, hepatitis C virus (HCV) has been intensively investigated to understand its biology and develop effective antiviral therapies. The efforts of the previous 25 years have... -
- CITED
-
- Close
- SHARE
-
- Close
- Clevudine therapy in patients with chronic hepatitis B
-
Lee KS
- KMID: 1381432
- Korean J Hepatol.
- 2009 Jun;15(2):119-121.
- doi: 10.3350/kjhep.2009.15.2.119
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
-
Yim HJ, Hwang SG
- KMID: 1705199
- Clin Mol Hepatol.
- 2013 Sep;19(3):195-209.
- doi: 10.3350/cmh.2013.19.3.195
Although much advancement has been achieved in the treatment of chronic hepatitis B, antiviral resistance is still a challenging issue. Previous generation antiviral agents have already developed resistance in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effectiveness of Lamivudine versus Entecavir in Patients with Hepatocellular Carcinoma: Watch out for Confounders!
-
Kim HY
- KMID: 2412089
- Gut Liver.
- 2016 Nov;10(6):869-870.
- doi: 10.5009/gnl16476
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- HBV Mutations During Antiviral Therapy in Patients with Chronic Hepatits B
-
Hwang SG
- KMID: 1119357
- Korean J Hepatol.
- 2005 Dec;11(4):311-319.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Monitoring and Treatment Strategy for Chronic Hepatitis B and Antiviral Resistant Hepatitis B
-
Kim TY, Sohn JH
- KMID: 782870
- Korean J Gastroenterol.
- 2007 Jun;49(6):346-355.
Clinical management of chronic hepatitis B is rapidly evolving after the recent development of new antiviral drugs. These agents have been shown to be effective in improving virological, biochemical, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
-
Hwang JA, Kim KB, Yang MJ, Lim SG, Hwang JC, Cheong JY, Cho SW, Kim SS
- KMID: 2164363
- Clin Mol Hepatol.
- 2015 Jun;21(2):131-140.
- doi: 10.3350/cmh.2015.21.2.131
BACKGROUND/AIMS: To determine the efficacies of entecavir (ETV) in nucleos(t)ide analogue (NA)-naive chronic hepatitis B (CHB) patients and in those with prior lamivudine (LAM) use who did not develop resistance. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection
-
Heo J, Cho M, Cho BM, Lee SM, Kim TO, Kim GH, Kang DH, Song GA
- KMID: 760719
- Korean J Hepatol.
- 2007 Jun;13(2):157-165.
BACKGROUND/AIM: Drug resistance is a major concern during nucleos(t)ide analogues therapy in patients with chronic hepatitis B virus (HBV) infections. The aim of this study was to measure the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of 48-week clevudine therapy for chronic hepatitis B
-
Kim MH, Kim KA, Lee JS, Lee HW, Kim HJ, Yun SG, Kim NH, Bae WK, Moon YS
- KMID: 1374961
- Korean J Hepatol.
- 2009 Sep;15(3):331-337.
- doi: 10.3350/kjhep.2009.15.3.331
BACKGROUND/AIMS: Clevudine is a nucleoside analogue that exhibits potent and sustained antiviral effects as a 24-week therapy for chronic hepatitis B (CHB). This study evaluated the efficacy and viral resistance... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B
-
Kim IH, Kim SH, Kim HC, Shin KD, Kim SW, Lee SO, Lee ST, Kim DG
- KMID: 760736
- Korean J Hepatol.
- 2007 Sep;13(3):349-362.
- doi: 10.3350/kjhep.2007.13.3.349
BACKGROUND/AIMS: Adefovir dipivoxil (ADV) resistance in patients with lamivudine-resistant chronic hepatitis B is not well understood. This study examined the initial virologic response (IVR) to ADV, the rate of... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure
-
Chin BS, Choi JY, Choi JY, Kim GJ, Kee MK, Kim JM, Kim SS
- KMID: 1783129
- J Korean Med Sci.
- 2009 Dec;24(6):1031-1037.
- doi: 10.3346/jkms.2009.24.6.1031
Resistance assays are useful in guiding decisions for patients experiencing virologic failure (VF) during highly-active antiretroviral therapy (HAART). We investigated antiretroviral resistance mutations in 41 Korean human immunodeficiency virus type... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Virologic Characteristics of Lamivudine Resistance in HBV-associated Chronic Liver Disease
-
Kim SS, Chung MG, Ju KT, Park DK, Kwon OS, Koo YS, Kim YK, Choi DJ, Hwang YJ, Kim JH
- KMID: 863116
- Korean J Hepatol.
- 2002 Dec;8(4):405-417.
BACKGROUND/AIMS: Lamivudine therapy in chronic hepatitis B has been shown to be effective in inhibiting HBV replication. However, lamivudine resistance has been developed with prolonged use. We studied to... -
- CITED
-
- Close
- SHARE
-
- Close
- A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B
-
Shin SR, Koh KC, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC
- KMID: 2167262
- Gut Liver.
- 2010 Dec;4(4):530-536.
BACKGROUND/AIMS: Adefovir (ADV) is the preferred drug for treating lamivudine (LAM)-resistant hepatitis B. However, not all patients who face virologic breakthrough during LAM treatment respond to ADV. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- KASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 1743722
- Clin Mol Hepatol.
- 2012 Jun;18(2):109-162.
- doi: 10.3350/cmh.2012.18.2.109
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
-
Kim JH, Ahn SH, Ko SY, Choe WH, Kim KH, Kwon SY
- KMID: 2373120
- Clin Mol Hepatol.
- 2016 Jun;22(2):241-249.
- doi: 10.3350/cmh.2015.0053
BACKGROUND/AIMS: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir (ADV) was the most potent regimen for chronic hepatitis B (CHB) patients who fail... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
-
Park JG, Park SY
- KMID: 2351024
- Clin Mol Hepatol.
- 2015 Sep;21(3):242-248.
- doi: 10.3350/cmh.2015.21.3.242
BACKGROUND/AIMS: We compared the efficacies of entecavir (ETV) plus tenofovir (TDF) and ETV plus adefovir (ADV) in chronic hepatitis B (CHB) patients with genotypic resistance to lamivudine (LAM) who showed... -
- CITED
-
- Close
- SHARE
-
- Close
